Senzime Management

Management criteria checks 2/4

Senzime's CEO is Philip Siberg, appointed in May 2023, has a tenure of 1.5 years. total yearly compensation is SEK4.61M, comprised of 55.2% salary and 44.8% bonuses, including company stock and options. directly owns 0.62% of the company’s shares, worth SEK4.05M. The average tenure of the management team and the board of directors is 2.8 years and 3.7 years respectively.

Key information

Philip Siberg

Chief executive officer

SEK 4.6m

Total compensation

CEO salary percentage55.2%
CEO tenure1.5yrs
CEO ownership0.6%
Management average tenure2.8yrs
Board average tenure3.7yrs

Recent management updates

Recent updates

Will Senzime (STO:SEZI) Spend Its Cash Wisely?

Feb 20
Will Senzime (STO:SEZI) Spend Its Cash Wisely?

We Think Senzime (STO:SEZI) Can Afford To Drive Business Growth

Sep 01
We Think Senzime (STO:SEZI) Can Afford To Drive Business Growth

Companies Like Senzime (STO:SEZI) Are In A Position To Invest In Growth

May 18
Companies Like Senzime (STO:SEZI) Are In A Position To Invest In Growth

How Much Of Senzime AB (publ) (STO:SEZI) Do Insiders Own?

Mar 15
How Much Of Senzime AB (publ) (STO:SEZI) Do Insiders Own?

Shareholders of Senzime (STO:SEZI) Must Be Delighted With Their 607% Total Return

Feb 16
Shareholders of Senzime (STO:SEZI) Must Be Delighted With Their 607% Total Return

We're Hopeful That Senzime (STO:SEZI) Will Use Its Cash Wisely

Jan 19
We're Hopeful That Senzime (STO:SEZI) Will Use Its Cash Wisely

Are Insiders Buying Senzime AB (publ) (STO:SEZI) Stock?

Dec 23
Are Insiders Buying Senzime AB (publ) (STO:SEZI) Stock?

What Kind Of Investors Own Most Of Senzime AB (publ) (STO:SEZI)?

Nov 26
What Kind Of Investors Own Most Of Senzime AB (publ) (STO:SEZI)?

CEO Compensation Analysis

How has Philip Siberg's remuneration changed compared to Senzime's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-SEK 131m

Jun 30 2024n/an/a

-SEK 130m

Mar 31 2024n/an/a

-SEK 131m

Dec 31 2023SEK 5mSEK 3m

-SEK 134m

Sep 30 2023n/an/a

-SEK 138m

Jun 30 2023n/an/a

-SEK 137m

Mar 31 2023n/an/a

-SEK 143m

Dec 31 2022SEK 450kn/a

-SEK 133m

Sep 30 2022n/an/a

-SEK 114m

Jun 30 2022n/an/a

-SEK 104m

Mar 31 2022n/an/a

-SEK 86m

Dec 31 2021SEK 400kn/a

-SEK 82m

Sep 30 2021n/an/a

-SEK 74m

Jun 30 2021n/an/a

-SEK 66m

Mar 31 2021n/an/a

-SEK 56m

Dec 31 2020SEK 100kn/a

-SEK 47m

Sep 30 2020n/an/a

-SEK 41m

Jun 30 2020n/an/a

-SEK 36m

Mar 31 2020n/an/a

-SEK 32m

Dec 31 2019SEK 100kn/a

-SEK 33m

Sep 30 2019n/an/a

-SEK 34m

Jun 30 2019n/an/a

-SEK 33m

Mar 31 2019n/an/a

-SEK 30m

Dec 31 2018SEK 100kn/a

-SEK 24m

Sep 30 2018n/an/a

-SEK 19m

Jun 30 2018n/an/a

-SEK 16m

Mar 31 2018n/an/a

-SEK 13m

Dec 31 2017SEK 131kn/a

-SEK 13m

Compensation vs Market: Philip's total compensation ($USD419.48K) is above average for companies of similar size in the Swedish market ($USD236.52K).

Compensation vs Earnings: Philip's compensation has increased whilst the company is unprofitable.


CEO

Philip Siberg (51 yo)

1.5yrs

Tenure

SEK 4,614,088

Compensation

Mr. Philip Siberg serves as the Chief Executive Officer of Stille Surgical, Inc. He serves as Chairman of the Board at Acarix AB (publ) since May 11, 2021. He was Co-Founder of Coala-Life Group AB (publ) a...


Leadership Team

NamePositionTenureCompensationOwnership
Philip Siberg
Chief Executive Officer1.5yrsSEK 4.61m0.62%
SEK 4.0m
Slavoljub Grujicic
Chief Financial Officer2.8yrsno data0.022%
SEK 143.1k
Johanna Tulkki
Chief Operating Officer4.8yrsno datano data
Fredrik Norrby
Chief Technology Officer1.8yrsno datano data
Rianne Waninge
Application Scientistno datano datano data
Paula Treutiger
Head of Communication & Investor Relations2.8yrsno datano data
Anders Selin
Executive Vice President of Sales5.2yrsno datano data
Michael Noble
Vice President Global Marketingless than a yearno datano data
Anders Jacobson
Chief Innovation Officer8.8yrsno data0.014%
SEK 91.9k
Catrin Molund
Executive Vice President of Business Development3.8yrsSEK 163.00kno data
Johanna Faris
Head of Q/RA/Sless than a yearno data0.0014%
SEK 9.0k

2.8yrs

Average Tenure

54yo

Average Age

Experienced Management: SEZI's management team is considered experienced (2.8 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Per Wold-Olsen
Chairman of the Boardless than a yearno data0.56%
SEK 3.7m
Goran Brorsson
Independent Director1.5yrsSEK 131.00k0.090%
SEK 582.6k
Adam Dahlberg
Vice Chairman of the Board24.8yrsSEK 350.00k5.55%
SEK 36.1m
Eva Walde
Independent Director3.7yrsSEK 210.00kno data
Sorin Brull
Chief Medical Officer8.8yrsSEK 1.31m3.33%
SEK 21.6m
Alfredo Abad-Gurumeta
Member of Scientific Advisory Boardno datano datano data
Bela Fulesdi
Member of Scientific Advisory Boardno datano datano data
Guy Cammu
Member of Scientific Advisory Boardno datano datano data
Hans Boer
Member of Scientific Advisory Boardno datano datano data
Claude Meistelman
Member of Scientific Advisory Boardno datano datano data
Jennifer Hunter
Member of Scientific Advisory Boardno datano datano data
Casper Claudius
Member of Scientific Advisory Boardno datano datano data

3.7yrs

Average Tenure

68yo

Average Age

Experienced Board: SEZI's board of directors are considered experienced (3.7 years average tenure).